openPR Logo
Press release

Coagulation Analyzers Market to Surge to US$ 13.17 Billion by 2025

02-15-2018 12:44 PM CET | Health & Medicine

Press release from: CMI - Research

Coagulation Analyzers Market to Surge to US$ 13.17 Billion

The Global Coagulation Analyzers Market, By Product Type (Analyzers (Clinical Laboratory Analyzers, Point of Care Analyzers) and Consumables (Reagents & Kits, Point-of-care strips), By Test Type (Activated Partial Thromboplastin Time Test, Prothrombin Time Test, D-Dimer Test, Fibrinogen Test, and Other Coagulation Tests), and By End User (Hospitals, Diagnostic Laboratories, Research Institutes, and Others) was valued at US$ 2,481.78 million in 2017 and is projected to exhibit a CAGR of 9.7% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.

Coagulation analyzers are used in diagnosis of bleeding disorders and thrombotic cases. The presence of coagulation analyzers these days are fully automated infuse with several advanced features to perform various functions such as cap piercing, primary tube sampling, dilution and automatic rerun. This ultimately, lowers total cost, improves the quality of patient care and assures regulatory compliance in the clinical laboratory. Instrumentation Laboratory — a Werfen company’s product — ACL TOP Family 50 series is designed for mid- to high-volume clinical laboratories, which offers the most advanced automation and quality management, for routine to specialty assays, including clotting, chromogenic, and immunological assays. These devices are highly sensitivity and offers accurate information and results thus, boosting the market growth of the coagulation analyzers over the forecast period.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1255

Browse 22 Market Data Tables and 28 Figures spread through 150 Pages and in-depth TOC on "Coagulation Analyzers Market, by Product Type (Analyzers (Clinical Laboratory Analyzers, Point of Care Analyzers) and Consumables (Reagents & Kits, Point-of-care strips), by Test Type (Activated Partial Thromboplastin Time Test, Prothrombin Time Test, D-Dimer Test, Fibrinogen Test and Other Coagulation Tests) and by End User (Hospitals, Diagnostic Laboratories, Research Institutes and Others) - Global Forecast to 2025"

Companies are focusing on developing next generation diagnostic analyzers to help to improve specificity, accuracy, and overall productivity without making the test expensive. They are developing portable and small sized analyzers, in order to enhance their market share. These innovative analyzers offer the same results in less turnaround time making them hassle free and feasible for the operators. For instance, in July 2017, Sysmex America, Inc. launched its XN-L automated hematology analyzers in the U.S. to meet the demand of lower-volume hematology analyzers. Moreover, in 2014, Siemens Healthineer’s product Xprecia Stride Coagulation Analyzer — a handheld device — received U.S. FDA approval for reliable monitoring of oral anticoagulation therapy with warfarin, a vitamin K antagonist. Moreover, in 2015, this same analyzer, received the Red Dot award for its design quality. The Red Dot Award is the largest and most recognized international product competition in the world for product design quality. These factors are expected to augment growth of the coagulation analyzers market over the forecast period.

Key players in the market are also engaged in strategic acquisitions and collaborations to increase their product portfolios and to introduce new platform technologies. For instance, in January 2012, Roche entered into a strategic alliance with Technoclone — a reagent specialist in thrombosis and cardiovascular diagnostics based in Vienna, Austria — to further expand the company’s reagent portfolio in coagulation diagnostics. This in turn, will help the Roche to retain the market share in in-vitro diagnostics. Furthermore, in August 2015, Abbott Laboratories entered into a definitive agreement to acquire Omnilab — a middleware provider for clinical diagnostics and blood transfusion laboratories — to expand lab offerings to international markets outside the U.S.

Key Takeaways of the Coagulation Analyzers Market:

The global coagulation analyzers market is expected to exhibit a CAGR of 9.7% over the forecast period (2017–2025). This is attributed to increasing adoption of these devices, as it provides accurate results in low turnaround time.

Among product types, clinical laboratory analyzers segment is expected to account for the largest share in the global coagulation analyzers market over the forecast period. This is attributed to increasing use of these devices in hospitals for hematological analysis of patients on a daily basis.

Among test types, prothrombin test segment accounted for the largest share in 2016, and this is owing to increasing incidence of cardiovascular and blood related diseases. According to Centers for Disease Control & Prevention (CDC), 2014, annually, 790,000 people in the U.S. suffer from heart attack, which indicates a potential need for immediate diagnosis and need for the early treatment

Prevailing trend of outsourcing hemostasis tests to diagnostic centers for quick reports is expected to be factor for growth of the diagnostic laboratories segment over the forecast period.

Some of the major players in the global coagulation analyzers market are Siemens AG, Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Instrumentation Laboratory, Sysmex Corporation, Beckman Coulter, Inc. (Danaher), Diamond Diagnostics, International Technidyne Corporation, Nihon Kohden Corporation, and Alere Inc.

To know the latest trends and insights related to coagulation analyzers market, click the link below: https://www.coherentmarketinsights.com/market-insight/coagulation-analyzers-market-1255

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Coagulation Analyzers Market to Surge to US$ 13.17 Billion by 2025 here

News-ID: 945024 • Views:

More Releases from CMI - Research

Global Generic Sterile Injectable Market - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Global Generic Sterile Injectable Market - Insights, Size, Share, Opportunity An …
The generic sterile injectable market is expected to gain steady traction in the foreseeable future as the sterile injectable products find its application across a wide number of diseases and medical condition. Manufacturers are focused on increasing the production of generic sterile injectable to meet the rising demands without compromising on the quality of the injectable. Apart from prevalence of chronic diseases, several other factors that are responsible to fuel the
Global Intravenous Access Devices Market - Catheters (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters, Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Global Intravenous Access Devices Market - Catheters (Midline Peripheral Cathete …
Rising incidence of cardiovascular disease due to increase in the prevalence of diabetes, high blood pressure cases and number of smokers worldwide is expected to favor the demand for intravenous access device around the globe. According to World Health Organization (WHO), in 2015 around 17.7 million people died due to cardiovascular disease worldwide. Furthermore, the majority of deaths are occurred in emerging economies due to high prevalence rate and lack of
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Lenalidomide, Decitabine, Deferasirox), and Geography - Insights, Size, Share, Opportunity Analysis, & Industry Forecast till 2025
Global Myelodysplastic Syndrome (MDS) Treatment Market, By Drug (Azacitidine, Le …
According to the American Society of Hematology, in 2016, prevalence of MDS ranged from 0.22-13.2 per 100,000, on all age categories and ethnicities globally. Increasing public awareness about the disease and introduction of new treatment for MDS will drive the growth of the market. Furthermore, growing aging population is analyzed to be a major factor propelling the growth of myelodysplastic syndrome treatment market. According to NCBI, 2012, the incidence of
Global Multiplexed Diagnostic Market by Product Type Reagents & Consumables and Instruments - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
Global Multiplexed Diagnostic Market by Product Type Reagents & Consumables and …
The multiplexed diagnostic market is gaining significant traction due to the rising prevalence of autoimmune diseases. According to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015, was estimated in 54 million U.S adults (22.7%) and by 2040, it is expected to be 78 million (26%) U.S adults age 18 years or older. The data represent the high prevalence of autoimmune diseases, indicating

All 5 Releases


More Releases for Analyzer

Egypt Blood Gas Analyzer and POC Immunoassay Analyzer Market
Rise in Testing due to increasing prevalence in cardiovascular and other non-communicable diseases is driving the demand for Blood Gas Analyzers, POC Immunoassay Analyzers and Transcutaneous Monitoring Devices in Egypt: Ken Research Installations of Blood Gas Analyzers, POC Immunoassay Analyzers and Transcutaneous Monitoring devices in Egypt is expected to grow as demand for technologically advanced products with extensive testing menu is rising within the healthcare facilities. Owing to the increasing demand for
Kuwait Blood Gas Analyzer and POC Immunoassay Analyzer Market: Ken Research
The report titled "Kuwait Blood Gas and POC Immunoassay Analyzer Market Outlook to 2026" provides a comprehensive analysis of the Diagnostic Equipment used in Hospitals and Independent Labs. The report also covers an overview and genesis of the industry, product-wise market size in terms of the installed base; market segmentation by type of device, type of workload, type of sales model, and type of end-users; a snapshot of the Blood
Global Blood coagulation analyzer Market, Blood coagulation analyzer Market 2020 …
The Blood coagulation analyzer market report provides a comprehensive view of global Blood coagulation analyzer industry. The study provides the industry overview with its growth analysis including CAGR, market shares, sales, gross margin, value, future trends, market opportunities etc. The study also includes analysis of historic data from 2015 to 2019 along with forecast from 2020 to 2025. Further, the Blood coagulation analyzer report contains drivers andrestraints of Blood coagulation
Global Dissolved Gas Analyzer Market | gas analyser , portable dga analyzer, por …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Global Dissolved Gas Analyzer Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future. This report provides strategic analysis of the Global Dissolved Gas Analyzer Market.
Process Liquid Analyzer Market Bolstered by at-line Process Liquid Analyzer Sale …
Process liquid analyzer acts as a watchdog for the parameters of liquid streams and industrial process and its output, thereby assisting end-users enhance plant and process productivity, process performance and profitability. On the account of process liquid analyzer lessening maintenance cost, intercepting unscheduled downtime and shielding pivotal process equipment from damages, the market has gained momentum. Besides, process liquid analyzer can be used on-line, off-line, in-line or at-line from the
Total Carbon Analyzer Global Market 2017 - 2026 | On-line TC Analyzer, Portable …
Press Release – 30 Aug 2018 Research and Development News -- . . Latest Update "Global Market Study on Total Carbon Analyzer: Pharmaceuticals Industry Projected to Hold High Revenue Share During 2017 - 2026" with Industries Survey | Global Current Growth and Future. ' ' This report by Persistence Market Research on the global total carbon analyzer market for the period 20172026 presents an outlook of the market across the globe. The primary objective